2'-deoxy-2'-methylenecytidine has been researched along with 1-arabinofuranosylcytosine-5'-stearylphosphate in 1 studies
Studies (2'-deoxy-2'-methylenecytidine) | Trials (2'-deoxy-2'-methylenecytidine) | Recent Studies (post-2010) (2'-deoxy-2'-methylenecytidine) | Studies (1-arabinofuranosylcytosine-5'-stearylphosphate) | Trials (1-arabinofuranosylcytosine-5'-stearylphosphate) | Recent Studies (post-2010) (1-arabinofuranosylcytosine-5'-stearylphosphate) |
---|---|---|---|---|---|
30 | 2 | 0 | 57 | 17 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tsukagoshi, S | 1 |
1 review(s) available for 2'-deoxy-2'-methylenecytidine and 1-arabinofuranosylcytosine-5'-stearylphosphate
Article | Year |
---|---|
[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues].
Topics: Animals; Antimetabolites, Antineoplastic; Arabinonucleotides; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Cytidine Monophosphate; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation | 1997 |